Navigation Links
Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
Date:12/7/2009

ex in consultation with the FDA. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future clinical trials and business prospects for KRX-0401, may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to successfully and cost-effectively complete clinical trials for KRX-0401; the risk that the data (both safety and efficacy) from the Phase 3 trial will not coincide with the data analyses from the Phase 1 / 2 clinical trial previously reported by the Company; and other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.


KERYX CONTACT:
Lauren Fischer
Director, Investor Relations
Keryx Biopharmaceuticals, Inc.
Tel: 212.531.5962
E-mail: lfischer@keryx.com

SOURCE Keryx Biopharmaceuticals, Inc.


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
9. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
11. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015  With the heroin epidemic in ... Jacksonville -based Lakeview Health drug and alcohol ... to explain why fentanyl is causing a new wave ... times more potent than pharmaceutical grade heroin and often ... risk of death skyrockets. "Fentanyl can be ...
(Date:8/28/2015)... HILL, N.C. , Aug. 28, 2015 /PRNewswire/ ... market research projects can slow down the decision-making ... It is, therefore, absolutely critical for biopharmaceutical companies ... market research approval process for quicker and more ... research by Best Practices, LLC, nearly three-quarters of ...
(Date:8/28/2015)... Calif. , Aug. 28, 2015  CytomX Therapeutics, ... treatment of cancer, today announced the filing of a ... and Exchange Commission (SEC) relating to a proposed initial ... shares to be offered and the price range for ... to list its common stock under the symbol "CTMX" ...
Breaking Medicine Technology:Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2Expediting the Pharmaceutical Market Research Process for Faster Insights 2CytomX Files Registration Statement for Proposed Initial Public Offering 2
... Diabetic patients diagnosed with peripheral neuropathy had lower ... when treated with a folate-enriched prescription medical food, ... Society for Pharmacoeconomics and Outcomes Research 12th Annual ... Inc. study, funded by Pamlab, L.L.C., which manufactures ...
... Genomma Lab Internacional, S.A.B. de C.V. (BMV: ... for the quarter ended September 30, 2009. All figures ... are stated in nominal Mexican pesos. Also, the following consolidated ... according to Mexican GAAP. , 3Q09 Highlights (vs. 3Q08) ...
Cached Medicine Technology:Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR 2Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR 3Genomma Lab Internacional Announces Third Quarter 2009 Results 2Genomma Lab Internacional Announces Third Quarter 2009 Results 3
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a growing number ... recently transitioned management companies to partner with Wound Care Advantage (WCA) to utilize ... center. , Transitioning wound care management providers can be a complex undertaking. ...
(Date:8/28/2015)... , ... August 28, 2015 , ... An online provider ... to make the purchase of CPAP equipment more affordable by offering shipping at no ... types of CPAP products and orders of any size. My Cpap Store is located ...
(Date:8/28/2015)... ... 28, 2015 , ... Approximately 2,000 United Methodists are expected ... helping children, a thank you to the many creative and generous ways in ... United Methodist initiative to end malaria deaths. , The Columbus Zoo and Aquarium ...
(Date:8/28/2015)... FL (PRWEB) , ... August 28, 2015 , ... The ... potential workers are qualified for the position they are applying for, they are unable ... this, many employers are considering altering drug testing policies in order to be able ...
(Date:8/28/2015)... CA (PRWEB) , ... August 28, 2015 , ... An ... journey that local pizza maker Paul LaRocco has gone through to open a pizzeria ... approval and permitting process tends to take several months, but the current process, having ...
Breaking Medicine News(10 mins):Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2
... Antonio Researcher, Educator Brings Expertise to Organization,s Focus ... on ... Komen for the Cure, the global,leader in the breast cancer ... its Scientific Advisory Board. (Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO ) ...
... Seniors for ,AFB Senior Site, ... of South Florida, TAMPA BAY, Fla., Oct. 2 ... American Foundation for the Blind to,fund and expand an AFB ... to lead more independent and comfortable lives. The AFB ...
... the Bill, CHICAGO, Oct. 2 The ... both congressional chambers of the State,Children,s Health Insurance ... provisions. The bill now heads to President,Bush for ... children, is one of the AGD,s top,legislative priorities ...
... Up-Time and Improved Overall ... Laboratory ... (http://www.siemens.com/diagnostics ) announced today,worldwide availability of version 2.0 software ... will be a required upgrade for,all existing customers and included ...
... MyCoupons, LLC announces today that,they have joined the fight ... They are committed to help educate the public about,breast ... cause. With the,recent introduction of the COUParison Shopping Engine, ... to use this current wave to,provide consumers with a ...
... NEW YORK, Oct. 2 October 11th marks World Sight ... that someone in the world,loses his or her sight every ... all the daunting statistics, one matters most of all: 75,percent ... observance of World Sight Day 2007, ORBIS International, a nonprofit,organization ...
Cached Medicine News:Health News:Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board 2Health News:Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board 3Health News:Verizon Awards $1.5 Million Grant to Expand American Foundation for the Blind's Web Site for Seniors With Age-Related Vision Loss 2Health News:Verizon Awards $1.5 Million Grant to Expand American Foundation for the Blind's Web Site for Seniors With Age-Related Vision Loss 3Health News:Verizon Awards $1.5 Million Grant to Expand American Foundation for the Blind's Web Site for Seniors With Age-Related Vision Loss 4Health News:AGD Applauds Congressional Support of SCHIP Reauthorization 2Health News:Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software 2Health News:Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software 3Health News:MyCoupons.com, LLC Joins the Fight Against Breast Cancer 2Health News:ORBIS and Alcon Team Up to Provide Eye Care Education to School Students 2Health News:ORBIS and Alcon Team Up to Provide Eye Care Education to School Students 3
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
... stability for contact lenses during surgery. This ... are precisely positioned to provide an easy ... are constructed from implant grade titanium for ... compatible with all Volk indirect and direct ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
Medicine Products: